Low plasma aldosterone despite normal plasma renin activity in uncomplicated type I diabetes mellitus: Effects of RAAS stimulation

European Journal of Clinical Investigation

Volumn 33, Issue 9, 2003, Pages 787-793

  Luik, P T ^a   Kerstens, M N ^a   Hoogenberg, K ^b   Navis, G J ^a   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

Aldosterone; Renin angiotensin system; Sodium intake; Type 1 diabetes mellitus

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; RENIN; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HORMONE ACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; SODIUM RESTRICTION;

ADULT; ALDOSTERONE; ANGIOTENSIN I; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIET, SODIUM-RESTRICTED; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MALE; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0042333495     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01215.x     Document Type: Article

References (39)

1. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999;10:2382-91.
2. de Azevedo MJ, Ramos OL, Gross JL. Renin-aldosterone axis in normoalbuminuric insulin-dependent diabetes mellitus patients with glomerular hyperfiltration. Diabetes Res Clin Pract 1995;27:205-10.
3. Winocour PH, Catalano C, Thomas TH, Wilkinson R, Alberti KG. Increased red cell sodium lithium countertransport activity, total exchangeable sodium, and hormonal control of sodium balance in normoalbuminuric type 1 diabetes. Diabet Med 1993;10:825-32.
4. Christlieb AR, Kaldany A, D'Elia JA, Williams GH. Aldosterone responsiveness in patients with diabetes mellitus. Diabetes 1978;27:732-7.
5. Beretta-Piccoli C, Elshater-Zanetti F, Shaw S, Cusi D, Weidmann P. Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects. Clin Sci (Colch) 1994;86:383-90.
6. Cronin CC, Barry D, Crowley B, Ferriss JB. Reduced plasma aldosterone concentrations in randomly selected patients with insulin-dependent diabetes mellitus. Diabet Med 1995;12:809-15.
7. O'Hare JA, Ferriss JB, Brady D, Twomey B, O'Sullivan DJ. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 1985;7:II43-II48.
8. Perez GO, Lespier L, Jacobi J, Oster JR, Katz FH, Vaamonde LA et al. Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Intern Med 1977;137:852-5.
9. de Chatel R, Weidmann P, Flammer J, Ziegler WH, Beretta-Piccoli C, Vettee W et al. Sodium, renin, aldosterone, catecholamines, and blood, pressure in diabetes mellitus. Kidney Int 1977;12:412-21.
10. Ferriss JB, O'Hare JA, Kelleher CC, Sullivan PA, Cole MM, Ross HF et al. Diabetic control and the renin-angiotensin system, catecholamines, and blood pressure. Hypertension 1985;7:II58-II63.
11. Beretta-Piccoli C, Weidmann P, Fraser R. Responsiveness of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus. Diabetes 1983;32:1-5.
12. Winocour PH, Waldek S, Baker R. Relationships between renin, aldosterone, blood pressure and renal function in hypertensive insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1989;7:99-108.
13. Iwasaki R, Kigoshi T, Uchida K, Morimoto S. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism. Acta Endocrinol (Copenh) 1989;121:83-9.
14. Azukizawa S, Kaneko M, Nakano S, Kigoshi T, Uchida K, Morimoto S. Angiotensin II receptor and postreceptor events in adrenal glomerulosa cells from streptozotocin-induced diabetic rats with hypoaldosteronism. Endocrinology 1991;129:2729-33.
15. Kigoshi T, Imaizumi N, Azukizawa S, Yamamoto I, Uchida K, Kanishi F et al. Effects of angiotensin II, adrenocorticotropin, and potassium on aldosterone production in adrenal zona glomerulosa cells from streptozotocin-induced diabetic rats. Endocrinology 1986;118:183-8.
16. Pratt JJ, Boonman R, Woldring MG, Donker AJ. Special problems in radioimmunoassay of plasma aldosterone without prior extraction and purification. Clin Chim Acta 1978;84:329-37.
17. Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 1999;10:1778-85.
18. Schneider EG, Robinson TV. Insulin prevents glucose induced inhibition of angiotensin II-stimulated aldosterone secretion. Horm Metab Res 1991;23:205-8.
19. Hoogenberg K, Sluiter WJ, Navis G, Van Haeften TW, Smit AJ, Reitsma WD et al. Exogenous norepinephrine induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus. J Am Soc Nephrol 1998;9:643-54.
20. Vierhapper H, Waldhausl W, Nowotny P. The effect of insulin on the rise in blood pressure and plasma aldosterone after angiotensin II in normal man. Clin Sci (Lond) 1983;64:383-6.
21. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-55.
22. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1172-9.
23. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994;94:2511-5.
24. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
25. Gans RO, Bilo HJ, Nauta JJ, Heine RJ, Donker AJ. Acute hyperinsulinemia induces sodium retention and a blood pressure decline in diabetes mellitus. Hypertension 1992;20:199-209.
26. Ferrannini E, Seghieri G, Muscelli E. Insulin and the renin-angiotensin-aldosterone system, influence of ACE inhibition. J Cardiovasc Pharmacol 1994;24 (Suppl. 3):S61-S69.
27. Gans RO, Bilo HJ, von Maarschalkerweerd WW, Heine RJ, Nauta JJ, Donker AJ. Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II. J Clin Invest 1991;88:512-8.
28. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DE. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990;15:861-6.
29. Natarajan R, Kathuria S, Lanting L, Gonzales N, Nadler J. Differential short- and long-term effects of insulin on ANG II action in human adrenal glomerulosa cells. Am J Physiol 1995;268:E100-E106.
30. Beretta-Piccoli C, Weidmann P. Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus. Am J Med 1981;71:829-35.
31. Christlieb AR, Janka HU, Kraus B, Gleason RE, Icasas-Cabral EA, Aiello LM et al. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 1976;25:268-74.
32. Kigoshi T, Morimoto S, Uchida K, Hosojima H, Yamamoto I, Imaizumi N et al. Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism. J Lab Clin Med 1985;105:195-200.
33. Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, Fujita T. Plasma adrenomedullin in diabetes. Lancet 1997;350:1449-50.
34. Trevisan R, Fioretto P, Semplicini A, Opocher G, Mantero F, Rocco S et al. Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic Volume expansion. Diabetes 1990;39:289-98.
35. Kudo T, Baird A. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature 1984;312:756-7.
36. Rebuffat P, Forneris ML, Aragona F, Ziolkowska A, Malendowicz LK, Nussdorfer GG. Adrenomedullin and its receptors are expressed in the zona glomerulosa of human adrenal gland. Evidence that ADM enhances proliferation and decreases apoptosis in cultured ZG cells. Int J Mol Med 2002;9:119-24.
37. Oelkers W, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI. Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res 1974;40:69-77.
38. Hollenberg NK, Chenitz WR, Adams DF, Williams GH. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 1974;54:34-42.
39. Aguilera G, Catt KJ. Regulation of aldosterone secretion during altered sodium intake. J Steroid Biochem 1983;19:525-30.